Form 4: Teladoc Health Insider Trades: Joseph Catapano
Statement of Changes in Beneficial Ownership
Joseph Catapano, Chief Accounting Officer at Teladoc Health, reported transactions involving restricted stock units and common stock sales.
Summary
- Joseph Ronald Catapano, Chief Accounting Officer at Teladoc Health, Inc., reported transactions on July 1st and July 2nd, 2026.
- On July 1, 2026, 2,083 restricted stock units (RSUs) were acquired, converting to common stock.
- On July 2, 2026, 653 shares of common stock were sold at $9.10 per share to cover tax withholding obligations related to RSU vesting.
- Following these transactions, Catapano beneficially owns 12,267 shares of common stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it reports routine insider transactions related to compensation and tax obligations, without indicating significant positive or negative developments for the company.
Positives
- The acquisition of 2,083 restricted stock units indicates continued equity-based compensation for the Chief Accounting Officer.
- The company facilitated the tax withholding obligation for the executive, suggesting a smooth process for equity vesting.
Negatives
- The sale of 653 shares to cover taxes implies a need to liquidate some of the vested equity, potentially reducing direct ownership.
Future Outlook
The filing does not contain forward-looking statements or guidance. It solely reports on past transactions.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, providing transparency into executive compensation and potential stock sales. These are common in the healthcare technology sector as companies utilize equity incentives.
Stakeholder Impact
- Shareholders: Increased transparency into executive compensation and potential stock sales.
- Employees: The transaction reflects standard equity compensation practices within the company.
- Management: The Chief Accounting Officer is managing their equity compensation and associated tax liabilities.
Next Steps
- Vesting of remaining restricted stock units according to the schedule (one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter).
Key Dates
| Date | Description |
|---|---|
| 07/01/2026 | Earliest transaction date reported; acquisition of restricted stock units. |
| 07/01/2026 | Grant date for 25,000 restricted stock units. |
| 07/02/2026 | Sale of common stock to cover tax withholding obligations. |
| 10/01/2024 | Grant date for restricted stock units with a specific vesting schedule. |
Keywords
Teladoc Health, TDOC, Form 4, Insider Trading, Joseph Catapano, Restricted Stock Units, Common Stock, Tax Withholding, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.